The prognostic role of cardiac troponin in hospitalized COVID-19 patients.

ABSTRACT:

Background and aims

Myocardial injury defined by elevation of cardiac troponins (cTn) in the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though not fully characterized yet. Using the Turkish nationwide centralized COVID-19 database, we sought to determine whether cTn measured within 24 h of admission may help identify 30-day all-cause mortality in hospitalized patients.

Methods

This retrospective cohort study was conducted at all hospitals in Turkey between March 11, 2020, and June 22, 2020. All hospitalized COVID-19 patients (≥18 years) who had cTn measurements within 24 h of admission were included. The primary outcome was 30-day all-cause mortality.

Results

A total of 14,855 COVID-19 patients (median age 49 years and 54% male) from 81

SUBMITTER: Tanboga IH 

PROVIDER: S-EPMC8052510 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature